A label-free electrochemical affisensor for cancer marker detection: The case of HER2

Bioelectrochemistry

Volumn 106, Issue , 2015, Pages 268-275

  Ravalli, Andrea ^a   da Rocha, Carolina Gomes ^a,b   Yamanaka, Hideko ^b   Marrazza, Giovanna ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Affibody; Biosensor; HER2; Nanoparticle; Tumor marker

Indexed keywords

AMINO ACIDS; BIOSENSORS; GOLD; NANOPARTICLES; SCANNING ELECTRON MICROSCOPY; TUMORS;

AFFIBODY; ANALYTICAL PERFORMANCE; ELECTROCHEMICAL TECHNIQUES; EXPERIMENTAL CONDITIONS; HER2; HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2); IMPEDIMETRIC BIOSENSORS; TUMOR MARKERS;

SURFACE PLASMON RESONANCE;

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GOLD NANOPARTICLE; TUMOR MARKER; VASCULOTROPIN; ERBB2 PROTEIN, HUMAN; GOLD; GRAPHITE; IMMOBILIZED ANTIBODY; NANOPARTICLE;

ARTICLE; BIOSENSOR; CANCER DIAGNOSIS; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; ELECTROCHEMICAL AFFISENSOR; ELECTROCHEMICAL ANALYSIS; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ELECTRODE; ELECTRON TRANSPORT; HUMAN; LIMIT OF DETECTION; ROENTGEN SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; SERUM; SURFACE PLASMON RESONANCE; BLOOD; CHEMISTRY; DEVICES; EQUIPMENT DESIGN; GENETIC PROCEDURES; IMMUNOLOGY; NEOPLASMS; PROCEDURES;

ANTIBODIES, IMMOBILIZED; BIOMARKERS, TUMOR; BIOSENSING TECHNIQUES; ELECTROCHEMICAL TECHNIQUES; ELECTRODES; EQUIPMENT DESIGN; GOLD; GRAPHITE; HUMANS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; NEOPLASMS; RECEPTOR, ERBB-2; SURFACE PLASMON RESONANCE;

EID: 84941258918     PISSN: 15675394     EISSN: 1878562X     Source Type: Journal    
DOI: 10.1016/j.bioelechem.2015.07.010     Document Type: Article

References (39)

1. Hutchinson L. Breast cancer: challenges, controversies, breakthroughs. Nat. Rev. Clin. Oncol. 2010, 7:669-670.
2. Sestak I., Cuzick J. Markers for the identification of late breast cancer recurrence. Breast Cancer Res. 2015, 17:10.
3. Wittner B.S., Sgroi D.C., Ryan P.D., Bruinsma T.J., Glas A.M., Male A., Dahiya S., Habin K., Bernards R., Haber D.A., Van't Veer L.J., Ramaswamy S. Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort. Clin. Cancer Res. 2008, 14:2988-2993.
4. Diaconu I., Cristea C., Harceaga V., Marrazza G., Berindan-Neagoe I., Sandulescu R. Electrochemical immunosensors in breast and ovarian cancer. Clin. Chim. Acta 2013, 425:128-138.
5. Hayes D.F. Tumor markers for breast cancer. Ann. Oncol. 1993, 4:807-819.
6. Mitri Z., Constantine T., O'Regan R. The HER2 receptor in breast cancer: pathophysiology, clinical use, and new advances in therapy. Chemother Res Pract 2012, 2012:743193.
7. Gutierrez C., Schiff R. HER2: biology, detection, and clinical implications. Arch. Pathol. Lab. Med. 2011, 135:55-62.
8. Tai W., Mahato R., Cheng K. The role of HER2 in cancer therapy and targeted drug delivery. J. Control. Release 2010, 146:264-275.
9. Al-Khafaji Q.A.M., Harris M., Tombelli S., Laschi S., Turner A.P.F., Mascini M., Marrazza G. An electrochemical immunoassay for HER2 detection. Electroanalysis 2012, 24:735-742.
10. Bettazzi F., Enayati L., Sánchez I.C., Motaghed R., Mascini M., Palchetti I. Electrochemical bioassay for the detection of TNF-α using magnetic beads and disposable screen-printed array of electrodes. Bioanalysis 2013, 5:11-19.
11. Burcu Bahadir E., Kemal Sezginturk M. Applications of electrochemical immunosensors for early clinical diagnostics. Talanta 2015, 132:162-174.
12. Gopinath S.C., Tang T.H., Citartan M., Chen Y., Lakshmipriya T. Current aspects in immunosensors. Biosens. Bioelectron. 2014, 57:292-302.
13. Meric B., Kerman K., Marrazza G., Palchetti I., Mascini M., Ozsoz M. Disposable genosensor, a new tool for the detection of NOS-terminator, a genetic element present in GMOs. Food Control 2004, 15:621-626.
14. Rusling J.F., Sotzing G., Papadimitrakopoulosa F. Designing nanomaterial-enhanced electrochemical immunosensors for cancer biomarker proteins. Bioelectrochemistry 2009, 76:189-194.
15. Taleat Z., Ravalli A., Mazloum-Ardakani M., Marrazza G. CA 125 immunosensor based on poly-anthranilic acid modified screen-printed electrodes. Electroanalysis 2013, 25:269-277.
16. Torrente-Rodriguez R.M., Campuzano S., Lopez-Hernandez E., Montiel V.R., Barderas R., Granados R., Sanchez-Puelles J.M., Pingarron J.M. Simultaneous detection of two breast cancer-related miRNAs in tumor tissues using p19-based disposable amperometric magnetobiosensing platforms. Biosens. Bioelectron. 2015, 66:385-391.
17. Zani A., Laschi S., Mascini M., Marrazza G. A new electrochemical multiplexed assay for PSA cancer marker detection. Electroanalysis 2011, 23:91-99.
18. Li Y., Zhang L., Li M., Pan Z., Li D. A disposable biosensor based on immobilization of laccase with silica spheres on the MWCNTs-doped screen-printed electrode. Chem. Cent. J. 2012, 6:103.
19. Zhang L., Li Y., Zhang L., Li D.W., Karpuzov D., Long Y.T. Electrocatalytic oxidation of NADH on graphene oxide and reduced graphene oxide modified screen-printed electrode. Int J Electrochem Sc 2011, 6:819-829.
20. Berti F., Lozzi L., Palchetti I., Santucci S., Marrazza G. Aligned carbon nanotube thin films for DNA electrochemical sensing. Electrochim. Acta 2009, 54:5035-5041.
21. Laschi S., Miranda-Castro R., Gonzalez-Fernandez E., Palchetti I., Reymond F., Rossier J.S., Marrazza G. A new gravity-driven microfluidic-based electrochemical assay coupled to magnetic beads for nucleic acid detection. Electrophoresis 2010, 31:3727-3736.
22. Laschi S., Palchetti I., Marrazza G., Mascini M. Enzyme-amplified electrochemical hybridization assay based on PNA, LNA and DNA probe-modified micro-magnetic beads. Bioelectrochemistry 2009, 76:214-220.
23. Mucelli S.P., Zamuner M., Tormen M., Stanta G., Ugo P. Nanoelectrode ensembles as recognition platform for electrochemical immunosensors. Biosens. Bioelectron. 2008, 23:1900-1903.
24. Pei X., Zhang B., Tang J., Liu B., Lai W., Tang D. Sandwich-type immunosensors and immunoassays exploiting nanostructure labels: a review. Anal. Chim. Acta 2013, 758:1-18.
25. Amaya-González S., de-los-Santos-Álvarez N., Miranda-Ordieres A.J., Lobo-Castañón M.J.S. Aptamer binding to celiac disease-triggering hydrophobic proteins: a sensitive gluten detection approach. Anal. Chem. 2014, 86:2733-2739.
26. Gonzalez-Fernandez E., de-los-Santos-Álvarez N., Lobo-Castanon M.J., Miranda-Ordieres A.J., Tunon-Blanco P. Impedimetric aptasensor for tobramycin detection in human serum. Biosens. Bioelectron. 2011, 26:2354-2360.
27. Gronwall C., Stahl S. Engineered affinity proteins-generation and applications. J. Biotechnol. 2009, 140:254-269.
28. Toh S.Y., Citartan M., Gopinath S.C., Tang T.H. Aptamers as a replacement for antibodies in enzyme-linked immunosorbent assay. Biosens. Bioelectron. 2015, 64:392-403.
29. Emami M., Shamsipur M., Saber R., Irajirad R. An electrochemical immunosensor for detection of a breast cancer biomarker based on antiHER2-iron oxide nanoparticle bioconjugates. Analyst 2014, 139:2858-2866.
30. Marques R.C., Viswanathan S., Nouws H.P., Delerue-Matos C., Gonzalez-Garcia M.B. Electrochemical immunosensor for the analysis of the breast cancer biomarker HER2 ECD. Talanta 2014, 129:594-599.
31. Chun L., Kim S.E., Cho M., Choe W.S., Nam J., Lee D.W., Lee Y. Electrochemical detection of HER2 using single stranded DNA aptamer modified gold nanoparticles electrode. Sens. Actuators B 2013, 186:446-450.
32. Patris S., De Pauw P., Vandeput M., Huet J., Van Antwerpen P., Muyldermans S., Kauffmann J.M. Nanoimmunoassay onto a screen printed electrode for HER2 breast cancer biomarker determination. Talanta 2014, 130:164-170.
33. Ardeshirpour Y., Chernomordik V., Hassan M., Zielinski R., Capala J., Gandjbakhche A. In vivo fluorescence lifetime imaging for monitoring the efficacy of the cancer treatment. Clin. Cancer Res. 2014, 20:3531-3539.
34. Gao J., Chen K., Miao Z., Ren G., Chen X., Gambhir S.S., Cheng Z. Affibody-based nanoprobes for HER2-expressing cell and tumor imaging. Biomaterials 2011, 32:2141-2148.
35. Ekerljung L., Lindborg M., Gedda L., Frejd F.Y., Carlsson J., Lennartsson J. Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line. Biochem. Biophys. Res. Commun. 2008, 377:489-494.
36. Lofblom J., Feldwisch J., Tolmachev V., Carlsson J., Stahl S., Frejd F.Y. Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications. FEBS Lett. 2010, 584:2670-2680.
37. Ravalli A., dos Santos G.P., Ferroni M., Faglia G., Yamanaka H., Marrazza G. New label free CA125 detection based on gold nanostructured screen-printed electrode. Sens. Actuators B 2013, 179:194-200.
38. Zhao J.H., Yan F., Ju H.X., Tang J.H., Qin J.W. Correlation between serum vascular endothelial growth factor and endostatin levels in patients with breast cancer. Cancer Lett. 2004, 204:87-95.
39. Orlova A., Magnusson M., Eriksson T.L., Nilsson M., Larsson B., Hoiden-Guthenberg I., Widstrom C., Carlsson J., Tolmachev V., Stahl S., Nilsson F.Y. Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res. 2006, 66:4339-4348.